Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Diabetes Care
|
November 30, 2006
Hyperinsulinemia and cognitive decline in a middle-aged cohort
Sara E Young, Arch G Mainous, Mark Carnemolla
American Family Physician
|
August 17, 2005
Treatment of early Parkinson's disease
Lori M Dickerson, Sara E Young, William M Simpson, et al.
Family Medicine
|
June 10, 2011
Teaching medical error apologies: development of a multi-component intervention
Ralph A Gillies, Stacie H Speers, Sara E Young, et al.
Family Medicine
|
February 2, 2006
Practice patterns in sildenafil prescribing
Sara E Young, Arch G Mainous, Vanessa A Diaz, et al.
The Oncologist
|
June 13, 2026
Clinical and Molecular Response to Vorasidenib in Post-Transplant Patient with IDH2-mutant Intrahepatic Cholangiocarcinoma
Vivian V Altiery De Jesus, Timothy McMahon, Sara E Young, et al.
Hepatology (Baltimore, Md.)
|
December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma
Daniel J Zabransky, Emma Kartalia, Jae W Lee, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Diabetes Care
|
November 30, 2006
Hyperinsulinemia and cognitive decline in a middle-aged cohort
Sara E Young, Arch G Mainous, Mark Carnemolla
American Family Physician
|
August 17, 2005
Treatment of early Parkinson's disease
Lori M Dickerson, Sara E Young, William M Simpson, et al.
Family Medicine
|
June 10, 2011
Teaching medical error apologies: development of a multi-component intervention
Ralph A Gillies, Stacie H Speers, Sara E Young, et al.
Family Medicine
|
February 2, 2006
Practice patterns in sildenafil prescribing
Sara E Young, Arch G Mainous, Vanessa A Diaz, et al.
The Oncologist
|
June 13, 2026
Clinical and Molecular Response to Vorasidenib in Post-Transplant Patient with IDH2-mutant Intrahepatic Cholangiocarcinoma
Vivian V Altiery De Jesus, Timothy McMahon, Sara E Young, et al.
Hepatology (Baltimore, Md.)
|
December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma
Daniel J Zabransky, Emma Kartalia, Jae W Lee, et al.
Page
of 1